Zobrazeno 1 - 10
of 222
pro vyhledávání: '"William B. Ershler"'
Autor:
William B. Ershler, MD, Laura M. De Castro, MD, MHSc, Zahra Pakbaz, MD, Aaron Moynahan, MA, Derek Weycker, PhD, Thomas E. Delea, MSIA, Irene Agodoa, MD, Ze Cong, PhD
Publikováno v:
Current Therapeutic Research, Vol 98, Iss , Pp 100696- (2023)
ABSTRACT: Background: Sickle cell disease (SCD) is an inherited, chronic, multifaceted blood disorder. Patients with SCD develop anemia, which has been associated with end-organ damage (EOD). Objectives: This retrospective, observational, repeated-me
Externí odkaz:
https://doaj.org/article/525589fc430748bca4276d0196e5e467
Autor:
Mary Steimer, Jessica Leabo, Hongkun Wang, David Heyer, Nancy Bowles, Laura Matthews, Timothy L. Cannon, Raymund Cuevo, William B. Ershler, Danielle Shafer, Sekwon Jang, Angela Pennisi, Amjaad Al-Hussain, Kirby Farrell, John F. Deeken
Publikováno v:
Oncology Issues. 37:20-26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::969e1c70119b49ba89cab807ce94ee9a
https://doi.org/10.1080/10463356.2022.2055427
https://doi.org/10.1080/10463356.2022.2055427
Autor:
William J. Evans, Luigi Ferrucci, Jeremy D. Walston, Marco Pahor, Andrew S. Artz, Jack M. Guralnik, Alejandro Lazo-Langner, William B. Ershler
Publikováno v:
Journal of the American Geriatrics Society. 70:891-899
BACKGROUND Up to 15% of people aged 60 and over are anemic, and the prevalence of anemia increases with age. In older men and women, anemia is associated with increases in the risk of death and all-cause hospitalization, poor functional capacity, qua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14bb6e0625c33655c40b9eba4abad440
https://doi.org/10.1111/jgs.17565
https://doi.org/10.1111/jgs.17565
Autor:
Danielle Shafer, Kirby Farrell, Sekwon Jang, John F. Deeken, William B. Ershler, Amjaad Al-Hussain, Jessica Leabo, Timothy L. Cannon, Angela Pennisi, Mary Steimer, David Heyer, Raymund Cuevo, Nancy Bowles, Hongkun Wang, Nancy Addison
Publikováno v:
JCO Oncology Practice. 17:e1286-e1292
PURPOSE:The COVID-19 pandemic has posed significant challenges in the care of patients with cancer, including how to manage outpatients who are COVID-positive but do not require hospitalization. We explored the use of a remote patient monitoring (RPM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e4879129490f17f8fd70666ddf4009d
https://doi.org/10.1200/op.20.00995
https://doi.org/10.1200/op.20.00995
Publikováno v:
International Immunopharmacology. 117:109950
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8401bb632ae1ac71bcb44f404b022cc0
https://doi.org/10.1016/j.intimp.2023.109950
https://doi.org/10.1016/j.intimp.2023.109950
Publikováno v:
Blood. 140:11157-11158
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a60ae0c26c81b4ed76279637c074f4d6
https://doi.org/10.1182/blood-2022-170745
https://doi.org/10.1182/blood-2022-170745
Publikováno v:
Blood
The issue of treating sickle cell disease with drugs that increase hemoglobin oxygen affinity has come to the fore with the US Food and Drug Administration approval in 2019 of voxelotor, the only antisickling drug approved since hydroxyurea in 1998.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::760f7d18ab36d5b422a7450edacad0aa
https://pubmed.ncbi.nlm.nih.gov/34197597
https://pubmed.ncbi.nlm.nih.gov/34197597
Autor:
William B. Ershler
Publikováno v:
Clinics in Geriatric Medicine. 35:295-305
The prevalence of anemia increases with advancing age, and despite thorough investigation, approximately one-third will be classified as "unexplained." Unexplained anemia (UA) is typically hypoproliferative, normocytic, and with low reticulocyte coun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::811cdf73fa86d730f5194fba5424af64
https://doi.org/10.1016/j.cger.2019.03.002
https://doi.org/10.1016/j.cger.2019.03.002
Publikováno v:
Transfusion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f4c50e133c11e39ab9c8b85ae235209
http://europepmc.org/articles/PMC7461458
http://europepmc.org/articles/PMC7461458
Autor:
Nhat Pham, Aaron Moynahan, Irene Agodoa, Zahra Pakbaz, Thomas E. Delea, Ze Cong, William B. Ershler, Laura M. De Castro, Derek Weycker
Publikováno v:
Blood. 136:27-28
Background: Sickle cell disease (SCD) is an inherited, chronic, and multifaceted condition. Anemia affects most patients with SCD, and low hemoglobin (Hb) levels have been demonstrated to be correlated with end-organ damage (EOD) such as stroke, chro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b22e350195cd7f2c79b04a77b6048596
https://doi.org/10.1182/blood-2020-140572
https://doi.org/10.1182/blood-2020-140572